Intra-dialytic hypotension (IDH) is a common complication of haemodialysis that impacts negatively on the patient's quality of life and can induce serious cardiovascular events.
Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ?20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, abdominal discomfort, yawning, sighing, vomiting, muscle cramps, restlessness, dizziness or fainting, and anxiety. It is the most common complications associated with hemodialysis treatment, which impairs the well-being of patient.
Apart from that, it can aggravate cardiac arrhythmias and influence the coronary or result in cerebral ischemic diseases.
In addition, the clinical IDH obstructs with an accurate dose delivery of dialysis therapeutics, as hypotension episodes lead to the compartment effect and cause suboptimal Kt/vUrea. Amongst the global population suffering from kidney failure, 76% of dialysis patients are reported to consume anti- hypertensive medications. Intra-dialytic hypotension is observed in 15% of the hemodialysis patients.
The global Intra-Dialytic Hypotension (IDH) market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Intra-Dialytic Hypotension (IDH) market based on company, product type, end user and key regions.
This report studies the global market size of Intra-Dialytic Hypotension (IDH) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intra-Dialytic Hypotension (IDH) in these regions.
This research report categorizes the global Intra-Dialytic Hypotension (IDH) market by top players/brands, region, type and end user. This report also studies the global Intra-Dialytic Hypotension (IDH) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Fresenius Medical Care
W. A. Baum
Siemens Corporate Research
Market size by Product
Hospital devices: instruments and systems
POC testing devices: various diagnostic kits and others
Market size by End User
Hospitals and research institutes
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Intra-Dialytic Hypotension (IDH) market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Intra-Dialytic Hypotension (IDH) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intra-Dialytic Hypotension (IDH) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intra-Dialytic Hypotension (IDH) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intra-Dialytic Hypotension (IDH) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intra-Dialytic Hypotension (IDH) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.